Compare ECOR & MXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECOR | MXE |
|---|---|---|
| Founded | 2005 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.0M | 54.4M |
| IPO Year | 2018 | 1994 |
| Metric | ECOR | MXE |
|---|---|---|
| Price | $6.49 | $13.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 49.2K | 4.3K |
| Earning Date | 04-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.66% |
| EPS Growth | ★ 53.51 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,182,000.00 | N/A |
| Revenue This Year | $28.92 | N/A |
| Revenue Next Year | $32.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 57.09 | N/A |
| 52 Week Low | $4.16 | $8.26 |
| 52 Week High | $13.81 | $14.30 |
| Indicator | ECOR | MXE |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 44.36 |
| Support Level | $4.64 | $13.07 |
| Resistance Level | $6.61 | $14.30 |
| Average True Range (ATR) | 0.70 | 0.30 |
| MACD | -0.06 | -0.17 |
| Stochastic Oscillator | 25.73 | 45.41 |
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.